Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial.

[1]  Yair Lotan,et al.  Treatment of Non‐Metastatic Muscle‐Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline , 2017, The Journal of urology.

[2]  J. Gschwend,et al.  Kurzform der S3-Leitlinie Harnblasenkarzinom , 2016, Der Urologe.

[3]  J. Witjes,et al.  The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic review. , 2014, European urology.

[4]  Steven L. Chang,et al.  Adjuvant chemotherapy for invasive bladder cancer: a 2013 updated systematic review and meta-analysis of randomized trials. , 2014, European urology.

[5]  A. Jemal,et al.  Clinical-pathologic stage discrepancy in bladder cancer patients treated with radical cystectomy: results from the national cancer data base. , 2014, International journal of radiation oncology, biology, physics.

[6]  J. Witjes,et al.  EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. , 2014, European urology.

[7]  D. Sjoberg,et al.  Lymph node-positive bladder cancer treated with radical cystectomy and lymphadenectomy: effect of the level of node positivity. , 2012, European urology.

[8]  R. Hautmann,et al.  Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients. , 2012, European urology.

[9]  A. Shokeir,et al.  Does the extent of lymphadenectomy in radical cystectomy for bladder cancer influence disease-free survival? A prospective single-center study. , 2011, European urology.

[10]  C. Stief,et al.  Association Between the Number of Dissected Lymph Nodes During Pelvic Lymphadenectomy and Cancer-Specific Survival in Patients with Lymph Node–Negative Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy , 2011, Annals of Surgical Oncology.

[11]  U. Studer,et al.  A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder. , 2010, European urology.

[12]  K. Jensen,et al.  Lymph node mapping in patients with bladder cancer undergoing radical cystectomy and lymph node dissection to the level of the inferior mesenteric artery , 2009, BJU international.

[13]  M. Makuuchi,et al.  The Clavien-Dindo Classification of Surgical Complications: Five-Year Experience , 2009, Annals of surgery.

[14]  C. Vale.  Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Update of a Systematic Review and Meta-Analysis of Individual Patient Data: Advanced Bladder Cancer (ABC) Meta-analysis Collaboration , 2005 .

[15]  M. Parmar,et al.  Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. , 2005, European urology.

[16]  M. Ghoneim,et al.  Lymph node involvement in patients with bladder cancer treated with radical cystectomy: a patho-anatomical study--a single center experience. , 2004, The Journal of urology.

[17]  S. Shariat,et al.  Stage specific lymph node metastasis mapping in radical cystectomy specimens. , 2004, The Journal of urology.

[18]  S. Kropf,et al.  Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. , 2004, The Journal of urology.

[19]  H. Herr.  Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy. , 2003, Urology.

[20]  V. Reuter,et al.  Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. 1 1 H. Barton Grossman, M.D , 2002 .

[21]  S. Groshen,et al.  Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  J. Thüroff,et al.  Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis , 2000, BJU international.

[23]  William D. Dupont,et al.  PS power and sample size program available for free on the internet , 1997 .

[24]  D. Skinner.  Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference. , 1982, The Journal of urology.

[25]  W. Leadbetter,et al.  Infiltrating Carcinoma of the Bladder1 , 1936 .